During the past decade, University of Virginia Center for Diabetes Technology conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 18 clinical trials were completed, i.e. on average, 52.9% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 14 clinical trials were completed. i.e. 82.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Virginia Center for Diabetes Technology" #1 sponsor was "University of Virginia" with 36 trials, followed by "Marc Breton" with 2 trials sponsored, "Sue Brown" with 2 trials sponsored, "Ananda Basu, MD" with 1 trials sponsored and "DexCom, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Virginia Center for Diabetes Technology" #1 collaborator was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 21 trials as a collaborator, "DexCom, Inc." with 18 trials as a collaborator, "Tandem Diabetes Care, Inc." with 15 trials as a collaborator, "Jaeb Center for Health Research" with 6 trials as a collaborator and "Roche Diagnostic Ltd." with 3 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "University of Virginia Center for Diabetes Technology" are "Type 1 Diabetes Mellitus" (19 trials), "Diabetes Mellitus, Type 1" (9 trials), "Type 1 Diabetes" (9 trials), "Type1 Diabetes Mellitus" (3 trials) and "Diabetes Mellitus" (2 trials). Many other conditions were trialed in "University of Virginia Center for Diabetes Technology" in a lesser frequency.

Most popular intervention types in "University of Virginia Center for Diabetes Technology" are "Device" (31 trials), "Other" (13 trials), "Behavioral" (3 trials), "Combination Product" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "t:slim X2 with Control-IQ Technology & Dexcom G6 CGM" (3 trials), "Artificial Pancreas" (2 trials), "Decision Support System" (2 trials), "Hybrid Closed Loop (HCL)" (2 trials) and "Sensor Augmented Pump Therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Virginia Center for Diabetes Technology" are 41 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "University of Virginia Center for Diabetes Technology". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in University of Virginia Center for Diabetes Technology, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of Virginia Center for Diabetes Technology, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 38 trials that are defined as “Not Applicable".